IL6 and neoplasm: In contrast to classical evidence that IL-6 is pro-tumorigenic in the tumor microenvironment, it has more recently been shown that trans-signaling of IL-6 can contribute to anti-tumor adaptive immunity by guiding lymphocyte trafficking to lymph nodes and tumors, as well as supporting their activation, proliferation, and polarization to anti-tumorigenic phenotypes (25).